2.515
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.65
Aprire:
$2.7
Volume 24 ore:
588.43K
Relative Volume:
0.82
Capitalizzazione di mercato:
$216.97M
Reddito:
$405.47M
Utile/perdita netta:
$53.66M
Rapporto P/E:
3.4931
EPS:
0.72
Flusso di cassa netto:
$131.28M
1 W Prestazione:
-9.86%
1M Prestazione:
-16.17%
6M Prestazione:
-36.97%
1 anno Prestazione:
-53.85%
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Confronta OSUR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OSUR
Orasure Technologies Inc
|
2.51 | 216.97M | 405.47M | 53.66M | 131.28M | 0.72 |
![]()
ISRG
Intuitive Surgical Inc
|
562.99 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
ALC
Alcon Inc
|
88.11 | 47.48B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
BDX
Becton Dickinson Co
|
171.83 | 47.33B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
RMD
Resmed Inc
|
247.55 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
79.70 | 16.11B | 3.93B | 415.40M | 384.70M | 2.06 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-01-03 | Ripresa | Evercore ISI | In-line |
2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-08-21 | Iniziato | Evercore ISI | Outperform |
2020-08-10 | Iniziato | Citigroup | Buy |
2020-08-10 | Iniziato | JP Morgan | Neutral |
2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-06-25 | Iniziato | Lake Street | Buy |
2020-04-21 | Ripresa | Stephens | Equal-Weight |
2018-10-23 | Ripresa | Raymond James | Mkt Perform |
2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
2017-11-02 | Downgrade | Jefferies | Buy → Hold |
2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-11-05 | Reiterato | Mizuho | Buy |
2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2015-01-23 | Reiterato | Mizuho | Buy |
2014-06-12 | Reiterato | Canaccord Genuity | Buy |
2014-06-11 | Reiterato | Mizuho | Buy |
2012-12-21 | Iniziato | Mizuho | Buy |
2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure in pact for celiac disease testing (OSUR:NASDAQ) - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac Testing | OSUR Stock News - GuruFocus
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com Canada
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OS - GuruFocus
OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus
OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus
OraSure Announces First Quarter 2025 Financial Results - The Manila Times
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies: Historically Cheap (NASDAQ:OSUR) - Seeking Alpha
Press Release Distribution & PR Platform - ACCESS Newswire
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th - The Manila Times
OraSure Technologies, Inc. Schedules Q1 2025 Earnings Conference Call for May 7, 2025 - Nasdaq
OraSure Q1 2025 Earnings Preview: Key Financial Metrics and Live Q&A Session Coming May 7 - Stock Titan
Your Guide to Rapid Testing for Syphilis, HIV & HCV - Labroots
OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference - marketscreener.com
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains? - Nasdaq
Premier Biotech Increases Offerings and Global Distribution Network with Recent Acquisitions - The Joplin Globe
Drug Screening Market is Expected to Reach $19.5 billion | MarketsandMarkets™ - The Globe and Mail
OraSure Technologies (NASDAQ:OSUR shareholders incur further losses as stock declines 12% this week, taking five-year losses to 75% - Yahoo Finance
Insider Stock Buying Reaches US$761.0k On OraSure Technologies - simplywall.st
OraSure Technologies Elects Jack Kenny to the Board of Directors - marketscreener.com
OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025 - Insider Monkey
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
OraSure announces $40M stock buy back - Lehigh Valley Business
OraSure announces $40 million stock buyback plan By Investing.com - Investing.com Australia
OraSure announces $40 million stock repurchase program - WFMZ.com
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Orasure Technologies Inc Azioni (OSUR) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):